Similar but not similar compounds….

Some months ago I wrote a blog post about biased ligand. It is still exciting area for me. BYW, the post is about Rexulti developed by Otuka Pharmaceutical. And the drug approved 19th Jan. 2018 in Japan for schizophrenia. Just by looking, Rexulit has very similar structure to Abilify. I interested the patent strategyContinue reading “Similar but not similar compounds….”